These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28815411)

  • 1. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
    El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
    Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors.
    Amin LHT; Shawer TZ; El-Naggar AM; El-Sehrawi HMA
    Bioorg Chem; 2019 Oct; 91():103159. PubMed ID: 31382056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
    Lu GQ; Li XY; Mohamed O K; Wang D; Meng FH
    Eur J Med Chem; 2019 Jun; 171():282-296. PubMed ID: 30927565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents.
    Du QR; Li DD; Pi YZ; Li JR; Sun J; Fang F; Zhong WQ; Gong HB; Zhu HL
    Bioorg Med Chem; 2013 Apr; 21(8):2286-2297. PubMed ID: 23490159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and
    Alzhrani ZMM; Alam MM; Neamatallah T; Nazreen S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1116-1123. PubMed ID: 32354237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido)benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
    Li XY; Liang JW; Mohamed O K; Zhang TJ; Lu GQ; Meng FH
    Eur J Med Chem; 2018 Jun; 154():267-279. PubMed ID: 29807332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antimicrobial activities of thiouracil derivatives containing triazolo-thiadiazole as SecA inhibitors.
    Cui P; Li X; Zhu M; Wang B; Liu J; Chen H
    Eur J Med Chem; 2017 Feb; 127():159-165. PubMed ID: 28039774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
    Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
    Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L
    Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity.
    Li XY; Zhang TJ; Kamara MO; Lu GQ; Xu HL; Wang DP; Meng FH
    Cell Death Dis; 2019 Jul; 10(7):532. PubMed ID: 31296849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
    Eissa IH; El-Naggar AM; El-Hashash MA
    Bioorg Chem; 2016 Aug; 67():43-56. PubMed ID: 27253830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
    Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
    Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes.
    Piras S; Carta A; Briguglio I; Corona P; Paglietti G; Luciani R; Costi MP; Ferrari S
    Eur J Med Chem; 2014 Mar; 75():169-83. PubMed ID: 24531230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
    Liu Y; Zhang C; Zhang H; Li M; Yuan J; Zhang Y; Zhou J; Guo H; Zhao L; Du Y; Wang L; Ren L
    Eur J Med Chem; 2015 Mar; 93():142-55. PubMed ID: 25668494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Mediated One-Pot, Three Component Synthesis, Docking and ADME Prediction of Novel 5-Amino-2-(4-chlorophenyl)-7-Substituted Phenyl-8,8a-dihydro-7H-(1,3,4)thiadiazolo(3,2-α)pyrimidine-6-carbonitrile Derivatives as Anticancer Agents.
    Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje AP
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase.
    Fritz TA; Tondi D; Finer-Moore JS; Costi MP; Stroud RM
    Chem Biol; 2001 Oct; 8(10):981-95. PubMed ID: 11590022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR-γ agonists and thymidylate synthase inhibitors.
    Nazreen S
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100021. PubMed ID: 33988883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.